- Home
- NIXX vs CGTX Comparison
NIXX vs CGTX Comparison
Compare NIXX & CGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NIXX
- CGTX
- Stock Information
- Founded
- NIXX 2010
- CGTX 2007
- Country
- NIXX United States
- CGTX United States
- Employees
- NIXX N/A
- CGTX N/A
- Industry
- NIXX
- CGTX Biotechnology: Pharmaceutical Preparations
- Sector
- NIXX
- CGTX Health Care
- Exchange
- NIXX NYSE
- CGTX Nasdaq
- Market Cap
- NIXX 49.9M
- CGTX 53.4M
- IPO Year
- NIXX N/A
- CGTX 2021
- Fundamental
- Price
- NIXX $1.90
- CGTX $0.72
- Analyst Decision
- NIXX
- CGTX Strong Buy
- Analyst Count
- NIXX 0
- CGTX 4
- Target Price
- NIXX N/A
- CGTX $2.83
- AVG Volume (30 Days)
- NIXX 321.4K
- CGTX 19.5M
- Earning Date
- NIXX 08-13-2025
- CGTX 08-07-2025
- Dividend Yield
- NIXX N/A
- CGTX N/A
- EPS Growth
- NIXX N/A
- CGTX N/A
- EPS
- NIXX N/A
- CGTX N/A
- Revenue
- NIXX $1,786,387.00
- CGTX N/A
- Revenue This Year
- NIXX N/A
- CGTX N/A
- Revenue Next Year
- NIXX N/A
- CGTX N/A
- P/E Ratio
- NIXX N/A
- CGTX N/A
- Revenue Growth
- NIXX 54.16
- CGTX N/A
- 52 Week Low
- NIXX $1.35
- CGTX $0.22
- 52 Week High
- NIXX $8.50
- CGTX $2.05
- Technical
- Relative Strength Index (RSI)
- NIXX N/A
- CGTX 59.79
- Support Level
- NIXX N/A
- CGTX $0.55
- Resistance Level
- NIXX N/A
- CGTX $0.87
- Average True Range (ATR)
- NIXX 0.00
- CGTX 0.11
- MACD
- NIXX 0.00
- CGTX 0.01
- Stochastic Oscillator
- NIXX 0.00
- CGTX 37.88
About NIXX NIXXY INC
Nixxy Inc is a hiring platform for the network of recruiters. It empowers businesses to recruit specialized talent faster with virtual teams of recruiters and AI job-matching technology.Recently, the Company acquired the license from GoLogiq, Inc. (GoLogiq), to operate its fintech technology (the GOLQ Technology) and sell products derived thereof, including its Createapp, Paylogiq, Gologiq, and Radix AI technology and products.. Its Recruiters On Demand provides businesses of all sizes access to virtual recruiters specialized by vertical industries to source, engage, and hire talent on an as-needed basis.
About CGTX Cognition Therapeutics Inc.
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.